Literature DB >> 15334844

Clinical and pathologic comparison of acute leptospirosis in dogs caused by two strains of Leptospira kirschneri serovar grippotyphosa.

Justin J Greenlee1, Carole A Bolin, David P Alt, Norman F Cheville, Claire B Andreasen.   

Abstract

OBJECTIVE: To develop a method for inducing acute leptospirosis in dogs. ANIMALS: 31 nine-week-old female Beagles. PROCEDURE: Beagles were randomly assigned to 2 inoculation groups or a control group. Dogs were inoculated on 3 successive days by conjunctival instillation of 5 x 10(7) cells of Leptospira kirschneri serovar grippotyphosa strain 82 (12 dogs) or strain RM 52 (14 dogs). Control dogs (n = 5) were similarly inoculated with sterile leptospiral culture media. Clinical signs, clinicopathologic variables, anti-leptospiral antibody titers, and evidence of leptospires in tissues and body fluids were evaluated. Dogs were euthanatized and necropsied on days 7, 14, 22, or 28 after inoculation or as required because of severe illness.
RESULTS: Clinical signs in infected dogs included conjunctivitis, lethargy, diarrhea, dehydration, vomiting, and icterus. Consistent clinicopathologic alterations included azotemia, hyperphosphatemia, increased anion gap, hyperbilirubinemia, and an increase in alkaline phosphatase activity. Leptospires were cultured from the kidneys (11/12), urine (6/9), aqueous humor (9/12), blood (12/12), and liver (12/12) of dogs inoculated with strain 82. Only 3 of 14 dogs became infected after inoculation with strain RM 52. Histopathologic lesions in infected dogs included interstitial nephritis, renal tubular degeneration and necrosis, pulmonary hemorrhage, and hepatic edema and perivasculitis. CONCLUSIONS AND CLINICAL RELEVANCE: Conjunctival exposure to L kirschneri serovar grippotyphosa strain 82 resulted in acute leptospirosis in all inoculated dogs, but only 3 of 14 dogs inoculated with strain RM 52 became infected. This method of infection by serovar grippotyphosa can be used to study the pathogenesis and prevention of leptospirosis in dogs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334844     DOI: 10.2460/ajvr.2004.65.1100

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  7 in total

1.  2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention.

Authors:  J E Sykes; K Hartmann; K F Lunn; G E Moore; R A Stoddard; R E Goldstein
Journal:  J Vet Intern Med       Date:  2010-12-13       Impact factor: 3.333

2.  Establishment of a leptospirosis model in guinea pigs using an epicutaneous inoculations route.

Authors:  Yan Zhang; Xiao-Li Lou; Hong-Liang Yang; Xiao-Kui Guo; Xiang-Yan Zhang; Ping He; Xu-Cheng Jiang
Journal:  BMC Infect Dis       Date:  2012-01-25       Impact factor: 3.090

3.  Recombinant antigens rLipL21, rLoa22, rLipL32 and rLigACon4-8 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays in dogs.

Authors:  Cuilian Ye; Weiwei Yan; Hua Xiang; Hongxuan He; Maosheng Yang; Muhammad Ijaz; Nicodemus Useh; Ching-Lin Hsieh; Patrick L McDonough; Sean P McDonough; Hussni Mohamed; Zhibang Yang; Yung-Fu Chang
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

4.  Prevalence and Genotype Allocation of Pathogenic Leptospira Species in Small Mammals from Various Habitat Types in Germany.

Authors:  Anna Obiegala; Dietlinde Woll; Carolin Karnath; Cornelia Silaghi; Susanne Schex; Sandra Eßbauer; Martin Pfeffer
Journal:  PLoS Negl Trop Dis       Date:  2016-03-25

5.  Leptospira seroprevalence in owned dogs from Spain.

Authors:  M C López; A Vila; J Rodón; X Roura
Journal:  Heliyon       Date:  2019-08-27

6.  A novel tetravalent Leptospira bacterin protects against infection and shedding following challenge in dogs.

Authors:  H L B M Klaasen; M van der Veen; M J C H Molkenboer; D Sutton
Journal:  Vet Rec       Date:  2012-11-23       Impact factor: 2.695

7.  Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bi-valent inactivated leptospirosis vaccine.

Authors:  J M Minke; R Bey; J P Tronel; S Latour; G Colombet; J Yvorel; C Cariou; A L Guiot; V Cozette; P M Guigal
Journal:  Vet Microbiol       Date:  2009-01-04       Impact factor: 3.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.